Soros Capital Management’s Boston Scientific BSX Stock Holding History

Soros Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,923	Closed	-$5.24M	–	50
2025 Q4	$5.24M	Buy	54,923 +50,439	+1,125%	+$4.95M	1.37%	20
2025 Q3	$438K	Sell	4,484 -1,606	-26%	-$166K	0.11%	56
2025 Q2	$654K	Sell	6,090 -147,656	-96%	-$14.9M	0.19%	45
2025 Q1	$15.5M	Buy	+153,746	New	+$15.5M	3.97%	8

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Soros Capital Management's BSX Position: Q1 2026 in Review

Soros Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 54,923 shares — an estimated $5.24M sold.

Soros Capital Management first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $15.5M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Soros Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Soros Capital Management sold 54,923 Boston Scientific shares in Q1 2026, an estimated $5.24M.
Soros Capital Management first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
Soros Capital Management's Boston Scientific position peaked at $15.5M in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Soros Capital Management's 13F filing for Q1 2026, filed 15 May 2026.